Relay Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Relay Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1750% to $25,546,000. Profit margin reached -1339%. Total operating expenses were $398,546,000.
Profit Margin
| 2018 | 0 | -48.78M | |
|---|---|---|---|
| 2019 | 0 | -66.50M | |
| 2020 | 82.65M | -49.01M | -59.3% |
| 2021 | 3.02M | -496.80M | -16401.72% |
| 2022 | 1.38M | -254.25M | -18411.22% |
| 2023 | 25.54M | -341.97M | -1338.66% |
RLAY Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 25.54M | 1.38M | 3.02M | 82.65M | 0 | 0 |
Cost of revenue | 5.26M | 4.13M | 3.92M | 3.54M | 2.84M | 0 |
Gross profit | 20.27M | -2.74M | -896K | 79.10M | -2.84M | 0 |
Operating exp. | ||||||
Research and development | 330.01M | 246.35M | 172.65M | 99.86M | 70.30M | 41.03M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 398.54M | 312.33M | 230.03M | 138.45M | 84.04M | 49.88M |
Operating income | -373M | -299.27M | -364.69M | -55.79M | -84.04M | -49.88M |
Other income (expenses), net | 31.02M | 8.76M | 826K | 3.38M | 8.74M | 1.10M |
Income before tax | -341.97M | -290.50M | -363.87M | -52.41M | -75.30M | -48.78M |
Income tax expense | 0 | -36.25M | 132.93M | -3.4M | -8.80M | 1.10M |
Net income | -341.97M | -254.25M | -496.80M | -49.01M | -66.50M | -48.78M |
Earnings per share | ||||||
Basic EPS | -2.79 | -2.27 | -5.22 | -1.15 | -15.53 | -19.63 |
Diluted EPS | -2.79 | -2.27 | -5.22 | -1.15 | -15.53 | -19.63 |
| Data source | Data source | Data source | Data source |